Evolution of enhanced innate immune evasion by SARS-CoV-2
暂无分享,去创建一个
Benjamin J. Polacco | Manolis Kellis | Irwin Jungreis | N. Krogan | K. Shokat | B. Polacco | P. Beltrão | K. Verba | Hannes Braberg | K. Obernier | J. Hiatt | A. García-Sastre | M. Bouhaddou | N. Jura | J. Batra | D. Swaney | M. Noursadeghi | G. Towers | D. Memon | C. Jolly | K. White | Alicia L. Richards | Jacqueline M. Fabius | M. Soucheray | A. Pelin | I. Goodfellow | P. Bonfanti | Ajda Rojc | R. Rosales | Lucy G. Thorne | A. Reuschl | L. Thorne | L. Zuliani-Alvarez | Jane Turner | M. Hosmillo | A. Fossati | Manisha Ummadi | A. Jahun | M. Whelan | R. Ragazzini | Kuei-Ho Chen | Marie L Bischof | Bhavya Harjai | Briana L McGovern | Yasuyuki Takeuchi | Margaret Soucheray | Briana L. McGovern | Ann-Kathrin Reuschl | Marie L. Bischof | Roberta Ragazzini | B. McGovern
[1] G. Kroemer,et al. Induction of transposable element expression is central to innate sensing , 2021 .
[2] V. Olieric,et al. Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions , 2021, Nature Communications.
[3] Graham W. Taylor,et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Nature.
[4] M. Santiago,et al. Interferon Resistance of Emerging SARS-CoV-2 Variants , 2021, bioRxiv.
[5] Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution , 2021, Virology.
[6] N. G. Davies,et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 , 2021, Nature.
[7] P. Calistri,et al. Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs , 2021, International Journal of Infectious Diseases.
[8] S. Mallal,et al. Altered Subgenomic RNA Expression in SARS-CoV-2 B.1.1.7 Infections , 2021, bioRxiv.
[9] Jie Zhou,et al. Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape , 2021, bioRxiv.
[10] S. Kissler,et al. Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2 , 2021, medRxiv.
[11] S. Kishigami,et al. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity , 2021, Nature Communications.
[12] M. Biggerstaff,et al. Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021 , 2021, MMWR. Morbidity and mortality weekly report.
[13] R. Siliciano,et al. Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption , 2021, Science Translational Medicine.
[14] Carl A. B. Pearson,et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Science.
[15] D. A. Jackson,et al. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity , 2020, Cell.
[16] E. Meshorer,et al. Transposable elements as sensors of SARS-CoV-2 infection , 2021 .
[17] M. Noursadeghi,et al. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation , 2020, bioRxiv.
[18] Haiyong Peng,et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity , 2020, Nature Communications.
[19] Lisa E. Gralinski,et al. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo , 2020, Science.
[20] Vineet D. Menachery,et al. Spike mutation D614G alters SARS-CoV-2 fitness , 2020, Nature.
[21] S. Chanda,et al. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling , 2020, Proceedings of the National Academy of Sciences.
[22] Miguel Correa Marrero,et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms , 2020, Science.
[23] Barbara B. Shih,et al. Genetic mechanisms of critical illness in COVID-19 , 2020, Nature.
[24] Steven M. Holland,et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.
[25] Jacques Fellay,et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.
[26] Andrew D Smith,et al. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore , 2020, bioRxiv.
[27] L. Ren,et al. Activation and evasion of type I interferon responses by SARS-CoV-2 , 2020, Nature Communications.
[28] V. Aguiar-Pulido,et al. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis , 2020, Communications Biology.
[29] Ze-Guang Han,et al. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70 , 2020, Cellular & Molecular Immunology.
[30] William L. Hamilton,et al. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study , 2020, The Lancet Infectious Diseases.
[31] Andrew R. Leach,et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection , 2020, Cell.
[32] D. Burton,et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model , 2020, Science.
[33] Rachel S. G. Sealfon,et al. SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes , 2020, bioRxiv.
[34] Benjamin J. Polacco,et al. A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.
[35] S. Baker,et al. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors , 2020, Proceedings of the National Academy of Sciences.
[36] M. Müller,et al. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform , 2020, Nature.
[37] Victor M Corman,et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[38] Benjamin M. Gyori,et al. Assembling a corpus of phosphoproteomic annotations using ProtMapper to normalize site information from databases and text mining , 2019, bioRxiv.
[39] Nora Schmidt. Novel Functions of Host TRIM28 in Restricting Influenza Virus Infections , 2019 .
[40] Steven L Salzberg,et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.
[41] Geo Pertea,et al. Transcriptome assembly from long-read RNA-seq alignments with StringTie2 , 2019, Genome Biology.
[42] Joshua M. Korn,et al. Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss , 2018, Nature Medicine.
[43] D. Sabatini,et al. RAB7A phosphorylation by TBK1 promotes mitophagy via the PINK-PARKIN pathway , 2018, Science Advances.
[44] J. Sáez-Rodríguez,et al. Benchmark and integration of resources for the estimation of human transcription factor activities , 2018, bioRxiv.
[45] G. Towers,et al. Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission? , 2017, Front. Immunol..
[46] Pedro Beltrão,et al. Benchmarking substrate-based kinase activity inference using phosphoproteomic data , 2016, bioRxiv.
[47] P. Borrow,et al. Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction , 2016, Cell host & microbe.
[48] Joel Selkrig,et al. An atlas of human kinase regulation , 2016, Molecular Systems Biology.
[49] Mariano J. Alvarez,et al. Network-based inference of protein activity helps functionalize the genetic landscape of cancer , 2016, Nature Genetics.
[50] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[51] S. Joel,et al. Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells , 2013, Science Signaling.
[52] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[53] Yufei Shan,et al. Tom70 mediates activation of interferon regulatory factor 3 on mitochondria , 2010, Cell Research.
[54] P. Cohen,et al. Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ϵ , 2009, Journal of Biological Chemistry.
[55] B. Lindenbach. Measuring HCV infectivity produced in cell culture and in vivo. , 2009, Methods in molecular biology.
[56] Anne E Carpenter,et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.
[57] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[58] H Green,et al. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. , 1975, Cell.